新規オキソイソキノリン誘導体 - Carna Bioscience Co., Ltd.

Title:

新規オキソイソキノリン誘導体

Document Type and Number:

Japanese Patent JP7015060

Kind Code:

B2

Abstract:

The present invention provides with an oxoisoquinoline derivative represented by the formula (I) (in the formula, Q and Rare as defined in the description) or a pharmaceutically acceptable salt thereof, which is useful as a Bruton's kinase inhibitor for treating cancer, B-cell lymphoma, chronic lymphocytic leukemia and the like.

More Like This:

JP2024515817	Phthalazinone derivatives as NLRP3 inflammasome inhibitors
WO/2020/053795	PROCESS FOR THE PREPARATION OF ACALABRUTINIB AND ITS INTERMEDIATES
JPS62249155	COLOR IMAGE FORMING METHOD

Inventors:

Wataru Kawabata
Kiyotaka Takao
Takayuki Irie
Saiko Asami
Masaaki Sawa
Shigeki Kashimoto

Application Number:

JP2018552969A

Publication Date:

February 02, 2022

Filing Date:

November 24, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Carna Bioscience Co., Ltd.

International Classes:

C07D487/04; A61K31/519; A61K31/5377; A61P19/08; A61P29/00; A61P35/00; A61P37/02; A61P43/00

Foreign References:

WO2013157022A1
CN104211703A
WO2015012149A1
WO2015041155A1
WO2013157021A1

Attorney, Agent or Firm:

Yamato Kento
Masahiro Nitta

Previous Patent: 2-substituted quinazoline compounds containing substituted heterocyclic groups and their usage

Next Patent: A device for cooling bottled beverages